Epigenomics AG (EPGNF)
OTCMKTS · Delayed Price · Currency is USD
1.120
+0.170 (17.89%)
At close: Jul 18, 2025

Epigenomics AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1127924
Upgrade
Market Cap Growth
24.83%-42.16%-75.69%-22.45%-60.45%-65.22%
Upgrade
Enterprise Value
1312-2-9-1716
Upgrade
Last Close Price
1.120.790.501.760.704.39
Upgrade
PS Ratio
187.98-4.687.511.3222.84
Upgrade
PB Ratio
----1.560.374.98
Upgrade
P/TBV Ratio
----0.375.05
Upgrade
EV/Sales Ratio
-----15.84
Upgrade
Debt / Equity Ratio
----2.930.020.18
Upgrade
Asset Turnover
0-0.030.050.390.08
Upgrade
Inventory Turnover
---4.310.910.67
Upgrade
Quick Ratio
21.221.991.7112.2510.852.05
Upgrade
Current Ratio
21.942.091.7712.6711.072.24
Upgrade
Return on Equity (ROE)
----194.42%-18.69%-173.22%
Upgrade
Return on Assets (ROA)
-3.80%-5.72%-19.46%-37.93%-16.54%-60.82%
Upgrade
Return on Capital (ROIC)
-6.28%-6.08%-25.81%-47.42%-19.18%-83.79%
Upgrade
Earnings Yield
-367.04%-341.98%-281.27%-256.24%-29.67%-60.75%
Upgrade
FCF Yield
--122.73%-359.84%-158.65%-51.16%-49.81%
Upgrade
Buyback Yield / Dilution
-0.21%-2.76%-4.93%-45.14%-93.95%-24.03%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.